Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tiso Group is a majority black-owned and managed South African investment holding company with interests in natural resources and financial services. It has been involved in private equity investments through subsidiaries such as Tiso Capital Partners No. 2 (Pty) Ltd and the Tiso Private Equity Fund 1 En Commandite Partnership. The group was notably involved in the acquisition of New Africa Investments Limited's media assets via the "Tiso Consortium," which included several other major investors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tiso Group.